George S T, Varghese M, John L, Balasubramanian A S
Clin Chim Acta. 1985 Jan 15;145(1):1-7. doi: 10.1016/0009-8981(85)90013-0.
Erythrocyte acetylcholinesterase (EC 3.1.1.7) and plasma pseudocholinesterase (EC 3.1.1.8) were determined from the day of admission up to 10 days in patients who have consumed organophosphate or carbamate poisons. In a number of patients, plasma pseudocholinesterase was completely inhibited on the day of admission but increased with the passage of days. Erythrocyte acetylcholinesterase was not completely inhibited and it also tended to increase with time in most cases. Patients in whom the erythrocyte acetylcholinesterase was very low and did not show an increase within the first few days expired indicating the prognostic importance of erythrocyte acetylcholinesterase. The profile of aryl acylamidase (EC 3.5.1.13) activity in plasma or erythrocytes showed a pattern similar to the respective cholinesterases. Moreover, whole blood aryl acylamidase activity was found to be a good index of erythrocyte acetylcholinesterase suggesting the prognostic usefulness of blood aryl acylamidase in the poisoned patients.
对摄入有机磷或氨基甲酸酯类毒物的患者,自入院当天起至10天内测定其红细胞乙酰胆碱酯酶(EC 3.1.1.7)和血浆假性胆碱酯酶(EC 3.1.1.8)。在一些患者中,血浆假性胆碱酯酶在入院当天完全被抑制,但随时间推移而升高。红细胞乙酰胆碱酯酶未被完全抑制,且在大多数情况下也随时间趋于升高。红细胞乙酰胆碱酯酶非常低且在最初几天内未升高的患者死亡,这表明红细胞乙酰胆碱酯酶具有预后重要性。血浆或红细胞中芳基酰胺酶(EC 3.5.1.13)活性的变化情况与相应胆碱酯酶相似。此外,发现全血芳基酰胺酶活性是红细胞乙酰胆碱酯酶的良好指标,提示血液芳基酰胺酶对中毒患者具有预后评估作用。